BREAST CANCER SCREENING: UPDATED RECOMMENDATIONS OF THE BRAZILIAN COLLEGE OF RADIOLOGY AND DIAGNOSTIC IMAGING, BRAZILIAN BREAST DISEASE SOCIETY, AND BRAZILIAN FEDERATION OF GYNECOLOGICAL AND OBSTETRICAL ASSOCIATIONS
Keywords:
Breast Neoplasms, Breast cancer screening, Mammography, Ultrasonography, mammary, Magnetic resonance imagingAbstract
Objective: To present the current breast cancer screening guidelines in Brazil, as devised by the Brazilian College of Radiology and Diagnostic Imaging (CBR), the Brazilian Society for Breast Disease (SBM) and the Brazilian Federation of Gynecological and Obstetrical Associations (FEBRASGO). Methods: We analyzed scientific studies available in Medline and Lilacs databases. In the absence of evidence, the guidelines reflected the consensus opinion of an expert panel. Guidelines: Annual mammography screening is recommended for women aged 40–74 years. Among women aged 75 years or older, annual mammography screening should be reserved for those with an expected survival of 7 years or more. Complementary ultrasound should be considered for women with dense breasts. Complementary magnetic resonance imaging is recommended for women at high risk. When available, an advanced form of mammography known as tomosynthesis can be considered as a means of screening for breast cancer.
Downloads
References
Myers ER, Moorman P, Gierisch JM, Havrilesky LJ, Grimm LJ, Ghate S, et al. Benefits and harms of breast cancer screening: a systematic review. JAMA. 2015;314:1615-34.
Feig SA. Screening mammography benefit controversies: sorting the evidence. Radiol Clin North Am. 2014;52:455-80.
Gonzaga CM, Freitas-Junior R, Souza MR, Curado MP, Freitas NM. Disparities in female breast cancer mortality rates between urban centers and rural areas of Brazil: ecological time-series study. Breast. 2014;23:180-7.
Freitas-Junior R, Rodrigues DCN, Corrêa RS, Peixoto JE, Oliveira HVCG, Rahal RMS. Contribution of the Unified Health Care System to mammography screening in Brazil, 2013. Radiol Bras. 2016;49:305-10.
Badan GM, Roveda Junior D, Ferreira CAP, Noronha Junior OA. Complete internal audit of a mammography service in a reference institution for breast imaging. Radiol Bras. 2014;47:74-8.
Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJ, et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet. 2011;378:1461-84.
Martins E, Freitas-Junior R, Curado MP, Freitas NM, Oliveira JC de, Silva CM. Temporal evolution of breast cancer stages in a population-based cancer registry in the Brazilian central region. Rev Bras Ginecol Obstet. 2009;31:219-23.
Castro Mattos JS de, Mauad EC, Syrjänen K, Longatto-Filho A, Haikel RL, Costa Vieira RA da, et al. The impact of breast cancer screening among younger women in the Barretos Region, Brazil. Anticancer Res. 2013;33:2651-5.
Urban LABD, Schaefer MB, Duarte DL, Santos RP, Maranhão NMA, Kefalas AL, et al. Recommendations of Colégio Brasileiro de Radiologia e Diagnóstico por Imagem, Sociedade Brasileira de Mastologia, and Federação Brasileira das Associações de Ginecologia e Obstetrícia for imaging screening for breast cancer. Radiol Bras. 2012;45:334-9.
Centre for Evidence-Based Medicine. Oxford centre for evidencebased medicine – levels of evidence [internet]. 2009 [cited on 2017 Mar. 23]. Available from: http://www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/
Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924-6.
Tarone RE. The excess of patients with advanced breast cancer in young women screened with mammography in the Canadian National Breast Screening Study. Cancer. 1995;75:997-1003.
Tabár L, Vitak B, Chen TH, Yen AM, Cohen A, Tot T, et al. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology. 2011;260:658-63.
Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet. 2012;380:1778-86.
Gotzsche PC, Jorgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2013;4:1-59.
Jorgensen KJ, Gotzsche PC. Breast cancer screening: benefit or harm? JAMA. 2016;315:1402.
Tabar L, Chen TH, Hsu CY, Wu WY-Y, Yen AM-F, Chen SL-S, et al. Evaluation issues in the Swedish Two-County Trial of breast cancer screening: an historical review. J Med Screen. 2017;24:27-33.
Villar VCFL, Seta MH de, Andrade CLT, Delamarque EV, Azevedo ACP. Evolution of mammographic image quality in the state of Rio de Janeiro. Radiol Bras. 2015;48:86-92.
Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L, et al. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years’ follow-up: a randomised controlled trial. Lancet. 2006;368:2053-60.
Hellquist BN, Duffy SW, Abdsaleh S, Björneld L, Bordás P, Tabár L, et al. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort. Cancer. 2011;117:714-22.
Jonsson H, Bordás P, Wallin H, Nyström L, Lenner P. Service screening with mammography in Northern Sweden: effects on breast cancer mortality – an update. J Med Screen. 2007;14:87-93.
Hartman M, Drotman M, Arleo EK. Annual screening mammography for breast cancer in women 75 years old or older: to screen or not to screen. Am J Roentgenol. 2015;204:1132-6.
Walter LC, Schonberg MA. Screening mammography in older women: a review. JAMA. 2014;311:1336-47.
Sung JS, Dershaw DD. Breast magnetic resonance imaging for screening high-risk women. Magn Reson Imaging Clin N Am. 2013;21:509-17.
Phi XA, Saadatmand S, De Bock GH, Warner E, Sardanelli F, Leach MO, et al. Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis. Br J Cancer. 2016;114:631-7.
França LKL, Bitencourt AGV, Paiva HLS, Silva CB, Pereira NP, Paludo J, et al. Role of magnetic resonance imaging in the planning of breast cancer treatment strategies: comparison with conventional imaging techniques. Radiol Brasil. 2017;50:76-81.
Lord SJ, Lei W, Craft P, Cawson JN, Morris I, Walleser S, et al. A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. Eur J Cancer. 2007;43:1905-17.
Riedl CC, Luft N, Bernhart C, Weber M, Bernathova M, Tea
M- KM, et al. Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density. J Clin Oncol. 2015;33:1128-35.
Kuhl C, Weigel S, Schrading S, Arand B, Bieling H, König R, et al. Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. J Clin Oncol. 2010;28:1450-7.
Bitencourt AGV. Subdividing BI-RADS category 4 breast lesions observed on magnetic resonance imaging: is it feasible? Radiol Bras. 2016;49(3):V.
Elkin EB, Klem ML, Gonzales AM, Ishill NM, Hodgson D, Ng AK, et al. Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin’s lymphoma: a multi-institutional, matched cohort study. J Clin Oncol. 2011;29:2466-73.
Ng AK, Garber JE, Diller LR, Birdwell RL, Feng Y, Neuberg DS, et al. Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin lymphoma. J Clin Oncol. 2013;31:2282-8.
Sung JS, Malak SF, Bajaj P, Alis R, Dershaw DD, Morris EA. Screening breast MR imaging in women with a history of lobular carcinoma in situ. Radiology. 2011;261:414-20.
Badan GM, Roveda Júnior D, Piato S, Fleury EFC, Campos MSD, Pecci CAF, et al. Diagnostic underestimation of atypical ductal hyperplasia and ductal carcinoma in situ at percutaneous core needle and vacuum-assisted biopsies of the breast in a Brazilian reference institution. Radiol Bras. 2016;49:6-11.
Smith RA, Andrews K, Brooks D, De Santis CE, Fedewa SA, Lortet-Tieulent J, et al. Cancer screening in the United States, 2016: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2016;66:96-114.
Houssami N, Abraham LA, Kerlikowske K, Buist DS, Irwig L, Lee J, et al. Risk factors for second screen-detected or interval breast cancers in women with a personal history of breast cancer participating in mammography screening. Cancer Epidemiol Biomarkers Prev. 2013;22:946-61.
Gweon HM, Cho N, Han W, Yi A, Moon HG, Noh DY, et al. Breast MR imaging screening in women with a history of breast conservation therapy. Radiology. 2014;272:366-73.
Giess CS, Poole PS, Chikarmane SA, Sippo DA, Birdwell RL. Screening breast MRI in patients previously treated for breast cancer: diagnostic yield for cancer and abnormal interpretation rate. Acad Radiol. 2015;22:1331-7.
Houssami N, Bernardi D, Pellegrini M, Valentini M, Fantò C, Ostillio L, et al. Breast cancer detection using single-reading of breast tomosynthesis (3D-mammography) compared to double-reading of 2D-mammography: evidence from a population-based trial. Cancer Epidemiol. 2017;47:94-9.
Skaane P, Bandos AI, Gullien R, Eben EB, Ekseth U, Haakenaasen U, et al. Comparison of digital mammography alone and digital mammography plus tomosynthesis in a population-based screening program. Radiology. 2013;267:47-56.
Ciatto S, Houssami N, Bernardi D, Caumo F, Pellegrini M, Brunelli S, et al. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study. Lancet Oncol. 2013;14:583-9.
Friedewald SM, Rafferty EA, Rose SL, Durand MA, Plecha DM, Greenberg JS, et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA. 2014;311:2499-507.
Gilbert FJ, Tucker L, Gillan MG, Willsher P, Cooke J, Duncan KA, et al. The TOMMY trial: a comparison of TOMosynthesis with digital MammographY in the UK NHS Breast Screening Programme — a multicentre retrospective reading study comparing the diagnostic performance of digital breast tomosynthesis and digital mammography with digital mammography alone. Health Technol Assess. 2015;19:i-xxv, 1-136.
Conant EF, Beaber EF, Sprague BL, Herschorn SD, Weaver DL, Onega T, et al. Breast cancer screening using tomosynthesis in combination with digital mammography compared to digital mammography alone: a cohort study within the PROSPR consortium. Breast Cancer Res Treat. 2016;156:109-16.
Freer PE, Winkler N. Synthesized digital mammography imaging. Radiol Clin North Am. 2017;55:503-12.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 Linei Augusta Brolini Dellê Urban, Luciano Fernandes Chala, Selma di Pace Bauab, Marcela Brisighelli Schaefer, Radiá Pereira dos Santos, Norma Medicis de Albuquerque Maranhão, Ana Lucia Kefalas, José Michel Kalaf, Carlos Alberto Pecci Ferreira, Ellyete de Oliveira Canella, João Emílio Peixoto, Heverton Leal Ernesto de Amorim, Helio Sebastião Amâncio de Camargo Junior
This work is licensed under a Creative Commons Attribution 4.0 International License.
